Literature DB >> 11559511

Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.

M D Phillips1, P McGraw, M J Lowe, V P Mathews, B E Hainline.   

Abstract

Phenylketonuria (PKU) is an autosomal recessive disorder caused by a deficiency of the enzyme phenylalanine hydroxylase (EC 1.14.16.1). Affected patients develop elevated plasma and tissue levels of phenylalanine and its related ketoacids. Untreated patients usually exhibit severe mental retardation and poor motor function, with characteristic T2 white matter signal abnormalities on conventional MR images. In the present study, we performed diffusion-weighted imaging in three PKU patients. All three patients demonstrated significantly restricted diffusion in all white matter areas examined.

Entities:  

Mesh:

Year:  2001        PMID: 11559511      PMCID: PMC7974588     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  16 in total

1.  Changes in brain water diffusion during childhood.

Authors:  M C Morriss; R A Zimmerman; L T Bilaniuk; J V Hunter; J C Haselgrove
Journal:  Neuroradiology       Date:  1999-12       Impact factor: 2.804

2.  Neuropathological findings in phenyl-pyruvic oligophrenia (phenyl-ketonuria).

Authors:  E C ALVORD; L D STEVENSON; F S VOGEL; R L ENGLE
Journal:  J Neuropathol Exp Neurol       Date:  1950-07       Impact factor: 3.685

3.  Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment.

Authors:  J Pietz; R Kreis; H Schmidt; U K Meyding-Lamadé; A Rupp; C Boesch
Journal:  Radiology       Date:  1996-11       Impact factor: 11.105

4.  Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria.

Authors:  M L Bauman; T L Kemper
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Myelin turnover in hyperphenylalaninaemia. A re-evaluation with the HPH-5 mouse.

Authors:  F A Hommes; L Moss
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Histopathologic correlates of abnormal water diffusion in cerebral ischemia: diffusion-weighted MR imaging and light and electron microscopic study.

Authors:  C Pierpaoli; A Righini; I Linfante; J H Tao-Cheng; J R Alger; G Di Chiro
Journal:  Radiology       Date:  1993-11       Impact factor: 11.105

Review 7.  White matter abnormalities in phenylketonuria: results of magnetic resonance measurements.

Authors:  K Ullrich; H Möller; J Weglage; G Schuierer; U Bick; A Ludolph; H Hahn-Ullrich; B Fünders; H G Koch
Journal:  Acta Paediatr Suppl       Date:  1994-12

8.  Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.

Authors:  S J Jones; G Turano; A Kriss; F Shawkat; B Kendall; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 9.  White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.

Authors:  U Bick; K Ullrich; U Stöber; H Möller; G Schuierer; A C Ludolph; C Oberwittler; J Weglage; U Wendel
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

10.  Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.

Authors:  M A Cleary; J H Walter; J E Wraith; F White; K Tyler; J P Jenkins
Journal:  J Pediatr       Date:  1995-08       Impact factor: 4.406

View more
  25 in total

Review 1.  Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review.

Authors:  Jun-ichi Takanashi; A James Barkovich; Ken-ichi Yamaguchi; Yoichi Kohno
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

Review 2.  Diffusion-weighted imaging of acute excitotoxic brain injury.

Authors:  Toshio Moritani; Wendy R K Smoker; Yutaka Sato; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

3.  Diffusion MRI findings in phenylketonuria.

Authors:  R N Sener
Journal:  Eur Radiol       Date:  2003-02-18       Impact factor: 5.315

4.  Multimodal magnetic resonance imaging study of treatment-naïve adults with attention-deficit/hyperactivity disorder.

Authors:  Tiffany M Chaim; Tianhao Zhang; Marcus V Zanetti; Maria Aparecida da Silva; Mário R Louzã; Jimit Doshi; Mauricio H Serpa; Fabio L S Duran; Sheila C Caetano; Christos Davatzikos; Geraldo F Busatto
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

5.  Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment.

Authors:  Steven Shinn-Forng Peng; Wen-Yih Isaac Tseng; Yin-Hsiu Chien; Wuh-Liang Hwu; Hon-Man Liu
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

6.  Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.

Authors:  Huiling Peng; Dawn Peck; Desirée A White; Shawn E Christ
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

7.  Metachromatic leukodystrophy: diffusion MR imaging findings.

Authors:  R Nuri Sener
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

8.  Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion.

Authors:  T Scarabino; T Popolizio; M Tosetti; D Montanaro; G M Giannatempo; R Terlizzi; S Pollice; A Maiorana; N Maggialetti; A Carriero; V Leuzzi; U Salvolini
Journal:  Radiol Med       Date:  2009-03-10       Impact factor: 3.469

9.  Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria.

Authors:  Renzo Manara; Alessandro P Burlina; Valentina Citton; Mario Ermani; Francesco Vespignani; Carla Carollo; Alberto B Burlina
Journal:  Neuroradiology       Date:  2009-08-04       Impact factor: 2.804

10.  Motor development skills of 1- to 4-year-old Iranian children with early treated phenylketonuria.

Authors:  Sepideh Nazi; Farzaneh Rohani; Firoozeh Sajedi; Akbar Biglarian; Arya Setoodeh
Journal:  JIMD Rep       Date:  2013-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.